Leading Cybersecurity Companies in Clinical Trials
Clinical trial software is vulnerable to breaches and ransomware attacks, as clinical trials become more decentralised and incorporate the use …
Clinical trial software is vulnerable to breaches and ransomware attacks, as clinical trials become more decentralised and incorporate the use …
Clinical pharmacology services help in the rational introduction of new medicines into healthcare. It is critical for new target molecules …
Clinical trial monitoring service companies help oversee the progress of clinical trials and ensure they are conducted, recorded, and reported …
England’s National Health Service (NHS) has kick started a study which will screen up to 100,000 newborn babies for over …
Immutep has announced the conclusion of subject enrolment in the Phase II segment of the AIPAC-003 clinical trial of eftilagimod …
Palvella Therapeutics has received a grant of up to $2.6m from the US Food and Drug Administration (FDA) Office of …
Abivax has enrolled the first subject in the Phase IIb ENHANCE-CD clinical trial of its lead investigational drug candidate obefazimod …
Summit Therapeutics has concluded subject enrolment in the Phase III HARMONi clinical trial of ivonescimab, along with platinum-doublet chemotherapy for …
Cloud-based clinical trials can reduce the huge expense and long lead times of traditional clinical trials. Clinical data sharing improves …
In the UK, heart disease is the leading cause of death in women. As heart disease is historically more prevalent …
Clinical trial data management involves gathering, refining and managing the data of an individual, according to regulatory requirements. It supports …
Clinical trials enable pharmaceutical, biopharmaceutical, life sciences and medical device companies to advance their discoveries into novel treatments and licensed …
Bioavailability studies are performed to determine the movement of an active ingredient through the system into the systemic circulation and …
Processa Pharmaceuticals has dosed the first subject in its Phase II clinical trial of Next Generation Capecitabine (NGC-Cap) to treat …
The National Institutes of Health (NIH) unit of the National Institute of Allergy and Infectious Diseases (NIAID) has selected Emergex …